Intervention not reported
Time to hemostasis (seconds) · vascular surgery patients who undergo creation of an anastomosis
The intervention showed no clear difference in time to hemostasis (seconds) (low certainty).
1 finding from 1 review
Intervention not reported
Failure of hemostatic intervention ( · vascular surgery patients who undergo creation of an anastomosis
It is very uncertain whether the intervention changes failure of hemostatic intervention ( (very low certainty).
1 finding from 1 review
Intervention not reported
Intraoperative blood loss (mL) · vascular surgery patients who undergo creation of an anastomosis
The intervention showed no clear difference in intraoperative blood loss (mL) (low certainty).
1 finding from 1 review
Intervention not reported
Operating time (minutes) · vascular surgery patients who undergo creation of an anastomosis
The intervention showed no clear difference in operating time (minutes) (low certainty).
1 finding from 1 review
Intervention not reported
Death from bleeding complications (up to 30 days · vascular surgery patients who undergo creation of an anastomosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Postoperative bleeding (up to 30 days · vascular surgery patients who undergo creation of an anastomosis
The intervention showed no clear difference in postoperative bleeding (up to 30 days (low certainty).
1 finding from 1 review
Intervention not reported
Unplanned return to the operating room (up to 30 days · vascular surgery patients who undergo creation of an anastomosis
The intervention showed no clear difference in unplanned return to the operating room (up to 30 days (low certainty).
1 finding from 1 review
Intervention not reported
Change in absolute walking distance from baseline (m) · people with intermittent claudication
1 finding from 1 review
Intervention not reported
Change in claudication distance from baseline (m) · people with intermittent claudication
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Amputation‐free survival · people with intermittent claudication
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Revascularisation‐free survival · people with intermittent claudication
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Major adverse cardiovascular events (MACE) · people with intermittent claudication
The intervention showed no clear difference in major adverse cardiovascular events (MACE) (low certainty).
1 finding from 1 review
Intervention not reported
Major adverse limb events (MALE) · people with intermittent claudication
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Above‐ankle amputation · people with intermittent claudication
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
MWD ‐ change from baseline · people with symptomatic peripheral arterial disease§
1 finding from 1 review
Change from baseline in 6MWT (metres) · people with symptomatic peripheral arterial disease§
1 finding from 1 review
PFWD (change in metres) (4–40 weeks' · people with symptomatic peripheral arterial disease§
1 finding from 1 review
ABI ‐ absolute value · people with symptomatic peripheral arterial disease§
1 finding from 1 review
All‐cause mortality · people with symptomatic peripheral arterial disease§
It is very uncertain whether supervised exercise therapy following vascular intervention changes mortality compared with vascular intervention alone (very low certainty).
1 finding from 1 review
Quality of Life: SF‐36 (physical component) · people with symptomatic peripheral arterial disease§
1 finding from 1 review